(3,4-DIFLUORO-2-(2-FLUORO-4-IODO-ANILINO)PHENYL)-(3-HYDROXY-3-((2S)-1-OXOPIPERIDIN-1-IUM-2-YL)AZETIDIN-1-YL)METHANONE
UNII N69Y48L5NP
Substance Identification & Data
This profile provides standardized clinical and technical data for (3,4-difluoro-2-(2-fluoro-4-iodo-anilino)phenyl)-(3-hydroxy-3-((2s)-1-oxopiperidin-1-ium-2-yl)azetidin-1-yl)methanone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N69Y48L5NP.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H20F3IN3O3 JAJSNRMNZJICKM-KRWDZBQOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3,4-difluoro-2-(2-fluoro-4-iodo-anilino)phenyl)-(3-hydroxy-3-((2s)-1-oxopiperidin-1-ium-2-yl)azetidin-1-yl)methanone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.